Monday, April 23, 2018

Emboline Finds $10M In Funding

Santa Cruza-based Emboline, a developer of a medical device for embolic protection during transcatheter aortic valve replacement (TAVR) procedures, has raised $10M in Series B funding, the company said last week. The company said the investment was led by SV Tech Ventures and Shangbay Capital, and also included other investors. The company said the round included $3M in new funding, plus another $7M in conversion of previously-issued convertible notes. More information »